Invesco Comstock Contrarian Equity ETF (CSTK)
BATS: CSTK · Real-Time Price · USD
33.61
+0.32 (0.96%)
Oct 20, 2026, 4:00 PM EDT - Market closed
| Assets | $182.92M |
| Expense Ratio | 0.35% |
| PE Ratio | 19.36 |
| Forward PE | 14.77 |
| Shares Out | 5.47M |
| Dividend | $0.60 (1.78%) |
| Ex-Dividend Date | Sep 21, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 34.42% |
| Volume | 18,966 |
| Open | 33.44 |
| Previous Close | 33.29 |
| Day's Range | 33.42 - 33.63 |
| 52-Week Low | 27.42 |
| 52-Week High | 34.33 |
| Beta | n/a |
| Holdings | 58 |
| Inception Date | May 7, 2025 |
About CSTK
Fund Home PageThe Invesco Comstock Contrarian Equity ETF (CSTK) is an exchange-traded fund that mostly invests in stocks across the whole market. The fund is an actively managed fund that aims for capital growth and income by broadly investing in undervalued companies of any market capitalization from around the world. CSTK was launched on May 7, 2025 and is issued by Invesco.
Top 10 Holdings
29.11% of assets| Name | Symbol | Weight |
|---|---|---|
| Alphabet Inc. | GOOGL | 3.90% |
| Microsoft Corporation | MSFT | 3.50% |
| Chevron Corporation | CVX | 3.08% |
| Cisco Systems, Inc. | CSCO | 2.90% |
| Wells Fargo & Company | WFC | 2.87% |
| Philip Morris International Inc. | PM | 2.84% |
| CVS Health Corporation | CVS | 2.60% |
| Bank of America Corporation | BAC | 2.56% |
| Elevance Health, Inc. | ELV | 2.50% |
| Merck & Co., Inc. | MRK | 2.35% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 21, 2026 | $0.12083 | Sep 25, 2026 |
| Jun 22, 2026 | $0.135 | Jun 26, 2026 |
| Mar 23, 2026 | $0.1508 | Mar 27, 2026 |
| Dec 22, 2025 | $0.19006 | Dec 26, 2025 |
| Sep 22, 2025 | $0.23031 | Sep 26, 2025 |
Performance
CSTK had a total return of 23.34% in the past year, including dividends. Since the fund's inception, the average annual return has been 24.94%.
News
Invesco to Advance Active Capabilities with Three New Active ETFs
Invesco launches three high-quality, active ETF strategies that effectively leverage the expertise of its in-house active managers. ATLANTA , May 7, 2025 /PRNewswire/ -- Invesco Ltd.
1 year ago - PRNewsWire